Tiziana Life Sciences Ltd

TLSAReported to SECin USCIK 0001723069Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 8. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 8
Form 4 lines at Tiziana Life Sciences Ltd, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Elrifi IvorChief Executive OfficerOption exercise—1,050,000 sharesSep 29, 2026Elrifi IvorChief Executive Officer—Exercise · Sep 29Option exercise1,050,000Sep 29, 2026
Elrifi IvorChief Executive OfficerOption exercise—1,050,000 sharesSep 29, 2026Elrifi IvorChief Executive Officer—Exercise · Sep 29Option exercise1,050,000Sep 29, 2026
CERRONE GABRIELE M—Open-market buy$41,93342,357 sharesAug 7, 2026CERRONE GABRIELE M$41,933Buy · Aug 7Open-market buy42,357Aug 7, 2026
CERRONE GABRIELE M—Open-market buy$16,65015,000 sharesAug 7, 2026CERRONE GABRIELE M$16,650Buy · Aug 7Open-market buy15,000Aug 7, 2026
Elrifi IvorChief Executive OfficerOpen-market buy$237,616237,616 sharesAug 6, 2026Elrifi IvorChief Executive Officer$237,616Buy · Aug 6Open-market buy237,616Aug 6, 2026